Hologic (NASDAQ:HOLX) Reaches New 12-Month High – Here’s What Happened

Shares of Hologic, Inc. (NASDAQ:HOLX) reached a new 52-week high during mid-day trading on Monday . The company traded as high as $76.01 and last traded at $76.0050, with a volume of 2400666 shares changing hands. The stock had previously closed at $75.65.

Hologic News Summary

Here are the key news stories impacting Hologic this week:

• Positive Sentiment: Blackstone and TPG completed the $17 billion take‑private acquisition of Hologic at $79.00 per share, so public shareholders receive the deal consideration and the company will be delisted. Hologic (HOLX) Goes Private
• Positive Sentiment: Official press release confirming close and leadership transition — private equity owners named Joe Almeida as CEO to lead Hologic under Blackstone/TPG ownership. This clarifies post‑deal management and reduces execution uncertainty. Blackstone and TPG Complete Acquisition
• Neutral Sentiment: Company announcement/confirmations of the takeover and leadership changes echoed across outlets (filings/PR). These are procedural confirmations of the already‑announced deal. Hologic Taken Private in Blackstone-TPG Acquisition
• Neutral Sentiment: Trading in HOLX was halted earlier for “news pending,” consistent with exchange protocol around a material deal close. That halt resolved with the deal confirmation. (No link — market notice)
• Negative Sentiment: Hologic will be removed from the S&P 500; Casey’s General Stores is being added to the index to replace HOLX. Removal from the index means ETFs and passive funds tracking the S&P will sell the shares — a temporary negative for short‑term liquidity, though offset by the cash‑out at $79. Casey’s General Stores (CASY) Shares Jump
• Negative Sentiment: Unusual options activity ahead of the close showed a surge in put purchases, indicating elevated hedging or bearish positioning prior to the announcement; such activity can signal uncertainty but is largely moot now that the deal closed. S&P 500 change coverage

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on HOLX shares. Evercore downgraded shares of Hologic from an “outperform” rating to an “in-line” rating and reduced their price target for the company from $79.00 to $78.00 in a research report on Monday, January 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Hologic in a research report on Wednesday, January 28th. Finally, Argus downgraded shares of Hologic from a “buy” rating to a “hold” rating in a research report on Monday, January 12th. Two equities research analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $78.42.

Hologic Price Performance

The company has a debt-to-equity ratio of 0.48, a quick ratio of 3.32 and a current ratio of 4.04. The stock has a market capitalization of $16.97 billion, a price-to-earnings ratio of 31.67, a P/E/G ratio of 2.24 and a beta of 0.70. The company has a 50-day moving average of $75.31 and a 200-day moving average of $73.83.

Hologic (NASDAQ:HOLX) last issued its quarterly earnings data on Thursday, January 29th. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.09 by ($0.05). Hologic had a return on equity of 19.58% and a net margin of 13.18%.The company had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.07 billion. During the same quarter in the prior year, the firm earned $0.87 earnings per share. The company’s revenue for the quarter was up 2.5% on a year-over-year basis. As a group, equities research analysts expect that Hologic, Inc. will post 4.28 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Harbor Capital Advisors Inc. acquired a new position in shares of Hologic during the 4th quarter worth approximately $27,000. Winnow Wealth LLC acquired a new position in shares of Hologic during the 3rd quarter worth approximately $26,000. Root Financial Partners LLC acquired a new position in shares of Hologic during the 3rd quarter worth approximately $27,000. SJS Investment Consulting Inc. raised its position in shares of Hologic by 341.5% during the 3rd quarter. SJS Investment Consulting Inc. now owns 468 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 362 shares during the last quarter. Finally, Smartleaf Asset Management LLC raised its position in shares of Hologic by 168.5% during the 3rd quarter. Smartleaf Asset Management LLC now owns 494 shares of the medical equipment provider’s stock worth $33,000 after purchasing an additional 310 shares during the last quarter. 94.73% of the stock is currently owned by institutional investors and hedge funds.

Hologic Company Profile

Hologic, Inc (NASDAQ: HOLX) is a global medical technology company specializing in women’s health. Headquartered in Marlborough, Massachusetts, the company develops and manufactures diagnostic products, imaging systems and surgical solutions designed to detect, diagnose and treat diseases with a primary focus on breast and skeletal health, gynecological conditions and molecular diagnostics. Its product portfolio includes digital mammography systems, 3D mammography solutions, bone densitometry equipment and molecular assays for infectious disease and oncology applications.

Since its founding in 1985, Hologic has grown through both internal innovation and strategic acquisitions.